Anthem, Inc. (NYSE:ANTM) Receives Average Rating of “Buy” from Analysts

Anthem, Inc. (NYSE:ANTM) has received an average rating of “Buy” from the twenty-two brokerages that are covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, eighteen have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $485.29.

Several research firms recently issued reports on ANTM. Truist boosted their target price on shares of Anthem from $490.00 to $540.00 and gave the company a “buy” rating in a research note on Wednesday, January 5th. Credit Suisse Group boosted their target price on shares of Anthem from $425.00 to $486.00 and gave the company an “outperform” rating in a research note on Thursday, October 21st. Citigroup upped their price objective on shares of Anthem from $445.00 to $497.00 and gave the stock a “buy” rating in a research report on Thursday, October 21st. Barclays upped their price objective on shares of Anthem from $450.00 to $485.00 and gave the stock an “overweight” rating in a research report on Thursday, October 21st. Finally, BMO Capital Markets upped their price objective on shares of Anthem from $465.00 to $500.00 and gave the stock an “outperform” rating in a research report on Friday, October 22nd.

Shares of NYSE:ANTM opened at $452.14 on Friday. The business’s 50-day moving average is $435.37 and its 200 day moving average is $403.86. Anthem has a 1 year low of $286.04 and a 1 year high of $470.02. The firm has a market capitalization of $109.74 billion, a P/E ratio of 20.29, a P/E/G ratio of 1.18 and a beta of 1.06. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.48 and a quick ratio of 1.48.

Anthem (NYSE:ANTM) last announced its earnings results on Tuesday, October 19th. The company reported $6.79 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $6.37 by $0.42. Anthem had a return on equity of 16.78% and a net margin of 4.12%. The company had revenue of $35.55 billion for the quarter, compared to analyst estimates of $35.35 billion. During the same period in the prior year, the company posted $4.20 EPS. The firm’s quarterly revenue was up 16.0% compared to the same quarter last year. On average, analysts expect that Anthem will post 25.96 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 21st. Investors of record on Friday, December 3rd were issued a $1.13 dividend. This represents a $4.52 dividend on an annualized basis and a dividend yield of 1.00%. The ex-dividend date of this dividend was Thursday, December 2nd. Anthem’s dividend payout ratio is currently 20.29%.

In related news, CAO Ronald W. Penczek sold 1,150 shares of the company’s stock in a transaction dated Thursday, October 28th. The shares were sold at an average price of $436.00, for a total value of $501,400.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.28% of the company’s stock.

Hedge funds have recently made changes to their positions in the business. Destiny Wealth Partners LLC purchased a new position in Anthem during the third quarter worth about $26,000. Canton Hathaway LLC purchased a new position in Anthem during the third quarter worth about $28,000. MV Capital Management Inc. boosted its stake in Anthem by 76.7% during the third quarter. MV Capital Management Inc. now owns 76 shares of the company’s stock worth $28,000 after buying an additional 33 shares during the period. Castleview Partners LLC purchased a new position in Anthem during the second quarter worth about $30,000. Finally, Itau Unibanco Holding S.A. purchased a new position in Anthem during the second quarter worth about $32,000. 87.91% of the stock is owned by institutional investors.

About Anthem

Anthem, Inc provides life, hospital and medical insurance plans. It offers a broad spectrum of network-based managed care health benefit plans to the large and small employer, individual, Medicaid, and Medicare markets. The company operates through the following segments: Commercial & Specialty Business, Government Business, IngenioRx and Other.

Further Reading: Investing in Dividend Stocks

Analyst Recommendations for Anthem (NYSE:ANTM)

Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.